The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study.

Deniz AygunSezgin SahinAmra AdrovicKenan BarutHaluk CokugrasYıldız CamcıogluOzgur Kasapcopur

Published in: Clinical rheumatology (2018)

We comment that the altered immune system of JIA can be responsible from the serious infections irrespective of immunosuppressive therapy. Biologic agents can be safely used in JIA evaluating the loss and benefit statement.

Keyphrases

juvenile idiopathic arthritis
rheumatoid arthritis
disease activity
systemic lupus erythematosus
stem cells
mesenchymal stem cells
bone marrow